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Pyrimidine and its derivatives demonstrate a diverse array of biological and 
pharmacological activities including anticonvulsant, antibacterial, antifungal, antiviral and 
anticancer properties. This broad spectrum of biochemical targets has been facilitated by the 
synthetic versatility of pyrimidine, which has allowed the generation of a large number of 
structurally diverse derivatives including analogues derived from substitution of the aryl 
ring, and/or derivatisation of the pyrimidine nitrogen and C2/C4/C5/C6 carbon positions. 
Pyrimidines are synthetically versatile substrates, where they can be used for the synthesis of 
a large variety of heterocyclic compounds and as raw material for drug synthesis. It was 
therefore the objective of this review to systematically evaluate the pharmacological 
properties of various substituted pyrimidine and collate these findings to be used as a guide 
for future structure-activity relationship and mode of action studies. This is the first review 
to comprehensively discuss the pyrimidine and its substituted derivatives. 
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Introduction 
Heterocyclic chemistry comprises at least half of all organic chemistry research 
worldwide. In particular, heterocyclic structures form the basis of many pharmaceutical, 
agrochemical and veterinary products. Heterocycles (Katritzky et al. 1996) make up an 
exceedingly important class of compounds. In fact more than half of all known organic 
compounds are heterocycles. Many natural drugs such as quinine, papaverine, emetine, 
theophylline, atropine, procaine, codeine, morphine and reserpine are heterocycles. Almost all 
the compounds we know as synthetic drugs such as diazepam, chlorpromazine, isoniazid, 
metronidazole, azidothymidine, barbiturates, antipyrine, captopril and methotrexate are also 
heterocycles. Some dyes, luminophores, pesticides and herbicides are also heterocyclic in 
nature. One of the main objectives of organic and medicinal chemistry is the design, synthesis 
and production of molecules having value as human therapeutic agents.  During the past 
decade, combinatorial chemistry has provided access to chemical libraries based on privileged 
structures, with heterocyclic structures (Katritzky et al. 2008) receiving special attention as they 
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belong to a class of compounds with proven utility in medicinal chemistry (Martins et al. 2004). 
There are numerous biologically active molecules with six-membered rings, containing two 
hetero atoms. Pyrimidine is a heterocyclic aromatic organic compound similar to benzene and 
pyridine, containing two nitrogen atoms at positions 1 and 3 of the six-member ring.  It 
is isomeric with two other forms of diazine Fig 1.  
 
 
 
 
 
 
 
Fig 1 Pyrimidine 
 
A pyrimidine has many properties in common with pyridine, as the number of nitrogen 
atoms in the ring increases the ring pi electrons become less energetic and electrophilic aromatic 
substitution gets more difficult while nucleophilic aromatic substitution gets easier. An example 
of the last reaction type is the displacement of the amino group in 2-aminopyrimidine by 
chlorine and its reverse. Reduction in resonance stabilization of pyrimidines may lead to 
addition and ring cleavage reactions rather than substitutions. One such manifestation is 
observed in the Dimroth rearrangement. Compared to pyridine, N-alkylation and N-
oxidation is more difficult, and pyrimidines are also less basic: The pKa value for protonated 
pyrimidine is 1.23 compared to 5.30 for pyridine. Pyrimidines can also be prepared within the 
laboratory by organic synthesis. One method is the classic Biginelli reaction. The Biginelli 
reaction is a multiple-component chemical reaction that creates 3,4-dihydropyrimidin-2(1H)-
ones from ethylacetoacetate, an aryl aldehyde (such as benzaldehyde), and urea Fig 2.  
 
 
 
 
 
 
 
 
 
 
Fig 2. Biginelli reaction 
 
This reaction was developed by Pietro Biginelli in 1891. The reaction can be catalyzed by 
 Brønsted acids and/or by Lewis acids such as boron trifluoride.  Several solid-phase protocols 
utilizing different linker combinations have been published. Dihydropyrimidinones, the 
products of the Biginelli reaction, are widely used in the pharmaceutical industry as calcium 
channel blockers, antihypertensive agents, and alpha-1-a-antagonists. Many other methods rely 
on condensation of carbonyls with amines for instance the synthesis of 2-Thio-6-methyluracil 
from thiourea and ethyl acetoacetate or the synthesis of 4-methylpyrimidine with 4,4-
dimethoxy-2-butanone and formamide. A novel method is by reaction of certain amides with 
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Carbonitriles under electrophilic activation of the amide with 2-chloro-pyridine and trifluoro 
methanesulfonic anhydride Fig 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3. Electrophilic activation of the amide 
 
In the last several decades, fused pyrimidine derivatives is a class of heterocyclic 
compound that have attracted significant interest in medicinal chemistry as they have a wide 
range of pharmaceutical and pharmacological applications such as antineoplastic, antiviral, 
antibacterial, expectorant, urinary tract infection, parkinsonism, anthelmintic, vasodilator, liver 
disorder, infections of the respiratory tract and ear,  treatment of gastrointestinal roundworms, 
peripheral neuropathies and disorders associated with hyperuricaemia. 
The fact that a majority of clinically active heterocyclic drugs possess a nitrogen hetero 
atomic system with one or two phenyl rings, at least one carbonyl group in their structure and 
presence of hydrogen donor/acceptor unit. In all of the pioneering experiments important core 
fragments (Bajda et al. 2007) is defined by presence of hydrogen donor/acceptor unit (HAD), 
hydrophobic domain (A) (aryl ring substituted/unsubstituted) and electron donor atom (D). 
This common features was found in the structures of well-established marketed drugs such as 
Uramustine, PiritreximIsetionate, Tegafur, Floxuridine, Fluorouracil, Cytarabine and 
Methotrexate etc., The pyrimidine and fused pyrimidine marketed drugs are tabulated in Table 
1.  
Table 1. List of Pyrimidine and fused pyrimidine marketed drugs 
 
Antineoplastic 
 
 
Uramustine 
 
 
 
 
 
5-Bis(2-chloroethylamino)uracil; 
[Bis(2-
chloroethyl)amino]pyrimidine-
2,4(1H,3H)-dione 
 
 
O
NH
H3CO
C
N
Tf2O;
N
Cl
N
N
OCH3
CH2Cl2
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PiritreximIsetio
nate 
 
 
 
2,4-Diamino-6-(2,5-
dimethoxybenzyl)-5-
methylpyrido[2,3-d}pyrimidine 
mono(2-
hydroxyethanesulphonate) 
 
 
 
 
Tegafur 
 
 
 
5-Fluoro-1-(tetrahydro-2- 
furyl)uracil;5-fluoro-1-
(tetrahydro-2-furyl)pyrimidine-
2,4(1H,3H)-dione 
N
NH
O
F
O
O
 
 
 
Floxuridine 
 
 
 
 
 
 
2’-Deoxy-5-flurouridine; 5-
Fluoro-2’-deoxyuridine; 1-(2-
Deoxy-β-d-ribofuranosyl)-5-
fluoropyrimidine-2,4(1H,3H)-
dione  
 
 
Fluorouracil 
 
 
5-Fluoropyrimidine-2,4(1H,3H)-
di-one  
 
 
Cytarabine 
 
 
 
 
1-β-d-Arabinofuranosylcytosine; 
4-Amino-1-β-d-
arabinofuranosylpyrimidine-
2(1H)-one 
 
 
 
Methotrexate 
 
 
 
N-{4-[(2,4-Diamino-6-
pteridinylmethyl)methylamino]b
enzoyl}-l-glutamic acid 
 
Antibacterial 
 
 
Trimethoprim 
 
 
5-(3,4,5-
Trimethoxybenzyl)pyrimidine-
2,4-diamine 
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Piromidic Acid 
 
 
 
8-Ethyl-5,8-dihydro-5-oxo-2-
(pyrrolidin-1-yl)pyrido[2,3-
d]pyrimidine-6-carboxylic acid 
 
 
 
Tetroxoprim 
 
 
5-[3,5-Dimethoxy-4-(2-
methoxyethoxy)benzyl]pyrimidi
ne- 
2,4-diyl-diamine 
N
N
NH2
H2N
O
O
O
O
 
 
 
Metioprim 
 
 
5-(3,5-Dimethoxy-4-
methylthiobenzyl-
2,4,diyldiamine 
 
 
Antifungal 
 
 
Flucytosine 
 
5-Fluorocytosine; 4-Amino-5-
fluoropyrimidine-2(1H)-one 
  
Antivirals 
 
 
Broxuridine 
 
 
 
5-Bromo-2’-deoxyuridine; 5-
Bromo-1-(2-deoxy-β-d-ribofura-
nosyl)pyrimidine-2,4(1H,3H)-
dione 
 
 
 
Idoxuridine 
 
 
 
 
 
2’-Deoxy-5-iodouridine 
 
NH
O
ON
O
HO
I
OH  
 
Anthelmintic 
 
Pyrantel 
Embonate 
 
1,4,5,6-Tetrahydro-1-methyl-
2[(E)-2-(2-thienyl)vinyl] 
pyrimidine 4,4’-methylenebis(3-
hydroxy-2-naphthoate 
 
 
 
Panneerselvam et al. / Research in Pharmacy 2(4) : 01-09, 2012 
6 
 
Vasodilators 
 
 
Dipyridamole 
 
 
2,2’,2’’,2’’’-[(4,8-
Dipiperidinopyrimido[5,4-
d]pyrimidine-2,6-
diyl)dinitrilo]tetraethanol 
 
 
 
 
 
Trapidil 
 
 
  
7-Diethylamino-5-methyl-1,2,4-
triazolo[1,5-a]pyrimidine 
 
Liver disorder 
 
 
Orotic Acid 
 
1,2,3,6-Tetrahydro-2,6-
dioxopyrimidine-4-carboxylic 
acid 
  
Respiratory tract and ear infections 
 
 
Brodimoprim 
 
 
 
2,4-Diamino-5-(4-bromo-3,5-
dimethoxybenzylpyrimidine 
 
Gastrointestinal roundworms infections 
 
 
Morantel Citrate 
 
 
 
1,4,5,6-Tetrahydro-1-methyl-2-
[2-(3-methyl-2-
thienyl)vinyl]pyrimidine citrate 
 
 
 
Peripheral neuropathies 
 
Isaxonine 
Phosphate 
 
2-(Isopropylamino)pyrimidine 
phosphate 
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Disorders associated with hyperuricaemia 
 
 
Tisopurine 
 
  
1H-Pyrazolo[3,4-d]pyrimidine-
4-thiol 
 
Expectorant and mucolytic 
 
 
Tasuldine 
 
 
2[(3Pyridylmethyl)thio]Pyrimidi
ne 
 
 
Urinary tract infections 
 
 
Pipemidic Acid 
 
 
 
 
8-Ethyl-5,8-dihydro-5-oxo-2-
(piperazin-1-yl)pyrido[2,3-
d]pyrimidine-6-carboxylic acid  
Parkinsonism 
 
 
Piribedil 
 
 
2-(4-Piperonylpiperazin-1-
yl)pyrimidine  
 
In general, lipophilicity is one of the most important parameter because it is mainly 
involved in pharmacokinetic processes such as absorption, distribution, metabolism, excretion, 
and toxicity (ADMET) and in ligand–target interactions (El-Baih et al. 2006). Lipophilicity is the 
molecular parameter of choice in numerous quantitative structure–activity relationships 
(QSAR) of different classes of compounds (Mossman, 1983). The promising activity of the 
compounds may be attributed to the substitutions at the hydrophobic domain. These marketed 
compounds contain substitutions and their positions are important core to produce 
pharmacological activities. 
 
Structure Activity Relationships (SAR) study 
As SAR studies give insights into the molecular properties causing receptor affinity and 
selectivity. The promising nature of the compounds may be attributed to the substitutions at the 
hydrophobic domain. These compounds had electron withdrawing and donating groups at the 
ortho, meta & para position of the hydrophobic aryl ring. In general it was observed that the 
substituted derivatives were more active than the other derivatives. This may be because of the 
fact that the substituted derivatives are better fitted into the receptor site. In all of the 
pioneering experiments important core fragments (Bruno-Blanch et al. 2003, Estrada and Pena, 
2000) is defined by presence of hydrogen donor/acceptor unit (HAD), hydrophobic domain (A) 
(aryl ring substituted/unsubstituted) and electron donor atom (D). This common features was 
found in the structures of well-established pyrimidine drugs (Fig 4). 
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Conclusions 
The article has outlined the biological activities of the pyrimidine scaffold. The biological 
activities of the pyrimidine indicates the maneuverability and versatility, which offer the 
medicinal chemist a continued interest in the pyrimidine skeleton in medicinal chemistry and 
drug development, the development of efficient and reliable methods for the construction of 
these molecules will ensure that this is an active and important area of research in heterocyclic 
chemistry. 
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A Five membered saturated heterocyclic ring substitution leads to anticancer and antiviral activities
B 2
nd and 4th position keto group substitution or amino 
substitution or  mixed keto, amino groups substitution
leads to anticancer, antiviral, antibacterial, antifungal, 
and treatment of respiratory tract infection and liver
disorder
B 2
nd position six or five membered saturated heterocyclic
 ring substitution leads to anthelmintic, antiparkinsonism
expectorant and treatment of GI disturbance, peripheral 
neuropathies
C 5
th position with halogen or substituted amine or
 saturated distal heterocyclic ring substitution leads to 
antibacterial and anticancer activities
D 5th  and 6th position fused with heterocyclic ring and 
o, m, p   substituted distal aryl ring substitution leads to 
anticancer, antiviral, antibacterial, vasodilation and 
treatment of urinary tract infection
Fig 4. SAR of pyrimidine marketed drugs
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